pentacyanoferrate (ii) has been researched along with oxadiazoles in 1 studies
| Studies (pentacyanoferrate (ii)) | Trials (pentacyanoferrate (ii)) | Recent Studies (post-2010) (pentacyanoferrate (ii)) | Studies (oxadiazoles) | Trials (oxadiazoles) | Recent Studies (post-2010) (oxadiazoles) |
|---|---|---|---|---|---|
| 11 | 0 | 5 | 6,057 | 257 | 2,359 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basso, LA; Calixto, JB; Campos, MM; de França Lopes, LG; Dos Santos Junior, A; Dos Santos, AJ; Rodrigues-Junior, VS; Santos, DS; Schneider, CZ; Sousa, EH; Souto, AA | 1 |
1 other study(ies) available for pentacyanoferrate (ii) and oxadiazoles
| Article | Year |
|---|---|
Activity of IQG-607, a new orally active compound, in a murine model of Mycobacterium tuberculosis infection.
Topics: Animals; Antitubercular Agents; Bacterial Load; Disease Models, Animal; Drug Evaluation, Preclinical; Ferrous Compounds; Isoniazid; Lung; Lung Diseases; Male; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles; Tuberculosis | 2012 |